HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients

by Karin Abbink, Petra LM Zusterzeel, Anneke J Geurts-Moespot, Antonius E van Herwaarden, Johanna MA Pijnenborg, Fred CGJ Sweep, Leon FAG Massuger
Published 2018-02-01